Combo Improves Survival in Refractory Colorectal Cancer

]]>(MedPage Today) -- Patients with chemorefractory metastatic colorectal cancer (CRC) had significant improvement in progression-free survival (PFS) with the addition of bevacizumab (Avastin) to trifluridine/tipiracil (FTD/TPC, Lonsurf), according...